128 related articles for article (PubMed ID: 6271425)
1. Do conventional plasma cyclic nucleotide phosphodiesterase inhibitors really work in all situations?
Wood PJ; Pao G; Ross G; Smith C
Clin Chim Acta; 1981 Sep; 115(3):405-8. PubMed ID: 6271425
[No Abstract] [Full Text] [Related]
2. Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from the cytosol of human platelets.
Grant PG; Mannarino AF; Colman RW
Thromb Res; 1990 Jul; 59(1):105-19. PubMed ID: 2169075
[TBL] [Abstract][Full Text] [Related]
3. Cyclic nucleotide phosphodiesterase activity and the platelet release reaction.
Taylor PM; Heptinstall S
Thromb Haemost; 1978 Apr; 39(2):550-1. PubMed ID: 27878
[No Abstract] [Full Text] [Related]
4. The effect of diamide on cyclic AMP levels and cyclic nucleotide phosphodiesterase in human peripheral blood lymphocytes.
Wedner HJ
Biochim Biophys Acta; 1980 Apr; 628(4):407-18. PubMed ID: 6245710
[TBL] [Abstract][Full Text] [Related]
5. Cyclic nucleotide phosphodiesterase inhibition by a benzoic acid derivative.
Killackey JJ; Killackey BA; Philp RB
Agents Actions; 1985 Dec; 17(2):192-6. PubMed ID: 2420162
[TBL] [Abstract][Full Text] [Related]
6. Activation of cyclic nucleotide phosphodiesterase from isolated human peripheral blood lymphocytes by mitogenic agents.
Epstein PM; Mills JS; Hersh EM; Strada SJ; Thompson WJ
Cancer Res; 1980 Feb; 40(2):379-86. PubMed ID: 6243252
[No Abstract] [Full Text] [Related]
7. [Pharmacologic value of cyclic nucleotide phosphodiesterase inhibitors].
Nemoz G; Prigent AF
Ann Pharm Fr; 1984; 42(2):99-112. PubMed ID: 6091520
[No Abstract] [Full Text] [Related]
8. Studies on plasma cyclic nucleotide, cyclic nucleotide phosphodiesterase, beta-thromboglobulin, and myoglobin response in patients with acute myocardial infarction.
Kurokawa Y; Fukuda I; Mozai T
Bull Osaka Med Sch; 1983 Oct; 29(2):85-97. PubMed ID: 6210124
[No Abstract] [Full Text] [Related]
9. Selective inhibition of rat lung cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase by cyclic nucleotides and their analogues and various drugs [proceedings].
Butt NM; Saeed SA; Collier HO
Biochem Soc Trans; 1980 Jun; 8(3):380-1. PubMed ID: 6249674
[No Abstract] [Full Text] [Related]
10. Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation.
Hidaka H; Hayashi H; Kohri H; Kimura Y; Hosokawa T; Igawa T; Saitoh Y
J Pharmacol Exp Ther; 1979 Oct; 211(1):26-30. PubMed ID: 226672
[No Abstract] [Full Text] [Related]
11. Inhibition of human lung cyclic GMP and cyclic AMP phosphodiesterases by certain nucleosides, nucleotides, and pharmacological phosphodiesterase inhibitors.
Glass WF; Moore JB
Biochem Pharmacol; 1979 Apr; 28(7):1107-12. PubMed ID: 87197
[No Abstract] [Full Text] [Related]
12. Serum cyclic 3',5'-nucleotide phosphodiesterase activity in myocardial infarction.
Nagasaka A; Nishijima K; Hidaka H; Tanaka T; Yoshida S; Nakai A; Ohyama T; Mizuno Y
Acta Cardiol; 1985; 40(6):613-20. PubMed ID: 3006409
[TBL] [Abstract][Full Text] [Related]
13. Serum cyclic 3',5'-nucleotide phosphodiesterase in patients with various thyroid disorders.
Nagasaka A; Hasegawa H; Hayami S; Hidaka H; Tanaka T; Niinomi M; Nihei N; Nakagawa H; Ohyama T; Aono T
Enzyme; 1985; 33(1):18-24. PubMed ID: 2985379
[TBL] [Abstract][Full Text] [Related]
14. Cyclic 3':5'-adenosine monophosphate phosphodiesterase and cyclic 3':5'-guanosine monophosphate phosphodiesterase of normal granulocytes and granulocytes of chronic myelogenous leukaemia.
UciĆski WS; Naskalski JW
Haematologia (Budap); 1986; 19(4):275-83. PubMed ID: 3028916
[TBL] [Abstract][Full Text] [Related]
15. High activity of cyclic 3',5'-nucleotide phosphodiesterase in sera of patient with phaeochromocytoma.
Nakai A; Nagasaka A; Ohyama T; Aono T; Iwase K; Hasegawa H; Hayami S; Hidaka H; Tanaka T; Niinomi M
Clin Endocrinol (Oxf); 1986 Apr; 24(4):409-14. PubMed ID: 3017609
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase inhibitors as tools in cyclic nucleotide research: a precautionary comment.
Wells JN; Kramer GL
Mol Cell Endocrinol; 1981 Jul; 23(1):1-9. PubMed ID: 6167475
[No Abstract] [Full Text] [Related]
17. Methylxanthine inhibitors of phosphodiesterases.
Wells JN; Miller JR
Methods Enzymol; 1988; 159():489-96. PubMed ID: 2457788
[No Abstract] [Full Text] [Related]
18. Differential effects of cyclic nucleotides and their analogs and various agents on cyclic GMP-specific and cyclic AMP-specific phosphodiesterases purified from guinea pig lung.
Davis CW; Kuo JF
Biochem Pharmacol; 1978 Jan; 27(1):89-95. PubMed ID: 202285
[No Abstract] [Full Text] [Related]
19. Analysis of the relationship between pharmacological inhibition of cyclic nucleotide phosphodiesterase and relaxation of canine tracheal smooth muscle.
Polson JB; Krzanowski JJ; Anderson WH; Fitzpatrick DF; Hwang DP; Szentivanyi A
Biochem Pharmacol; 1979 Apr; 28(8):1391-5. PubMed ID: 87201
[No Abstract] [Full Text] [Related]
20. Inhibition of human lung cyclic nucleotide phosphodiesterases by proxyphylline, theophylline and their metabolites.
Selvig K; Bjerve KS
Acta Pharmacol Toxicol (Copenh); 1982 Sep; 51(3):250-2. PubMed ID: 6291318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]